Understanding Cancer
... new HPV vaccine Pap testing should continue less frequently at the discretion of the medical provider and patient after three or more annual tests have been normal ...
... new HPV vaccine Pap testing should continue less frequently at the discretion of the medical provider and patient after three or more annual tests have been normal ...
Cancer spread to bones life expectancy
... but new therapies are extending life beyond what was possible a few years ago. Treatment may increase life expectancy in stage 4 breast cancer. Photo Credit Stockbyte/Stockbyte/Getty Images Life expectancy for a stage IV prostate cancer patient is often not very encouraging because not only is the c ...
... but new therapies are extending life beyond what was possible a few years ago. Treatment may increase life expectancy in stage 4 breast cancer. Photo Credit Stockbyte/Stockbyte/Getty Images Life expectancy for a stage IV prostate cancer patient is often not very encouraging because not only is the c ...
FREND™ PSA Plus Prostate Specific Antigen
... The FREND™ PSA Plus is designed for in vitro DIAGNOSTIC USE ONLY for the quantitative measurement of total Prostate Specific Antigen (PSA) in human serum, heparinized plasma, and EDTA plasma using the FREND™ System. This device is indicated for the serial measurement of total PSA in serum, hepariniz ...
... The FREND™ PSA Plus is designed for in vitro DIAGNOSTIC USE ONLY for the quantitative measurement of total Prostate Specific Antigen (PSA) in human serum, heparinized plasma, and EDTA plasma using the FREND™ System. This device is indicated for the serial measurement of total PSA in serum, hepariniz ...
INTRODUCTION - HAL
... Prostate cancer (PCa) is the most common solid malignancy in men in EU and the second cause of death attributable to cancer [1]. Despite of the widespread use of prostate-specific antigen (PSA) screening some patients are still diagnosed with a locally advanced prostate cancer. Therapeutic strategy ...
... Prostate cancer (PCa) is the most common solid malignancy in men in EU and the second cause of death attributable to cancer [1]. Despite of the widespread use of prostate-specific antigen (PSA) screening some patients are still diagnosed with a locally advanced prostate cancer. Therapeutic strategy ...
Castration resistant prostate cancer LAHCENE
... * Age-standardized to the 1991 Canadian Standard Population. Age-standardization is a statistical method that removes the effect of age on the calculated rate. It allows rates to be compared over time or across provinces and territories. ...
... * Age-standardized to the 1991 Canadian Standard Population. Age-standardization is a statistical method that removes the effect of age on the calculated rate. It allows rates to be compared over time or across provinces and territories. ...
Open clinical uro-oncology trials in Canada
... National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) Trial design: A phase III study comparing radical prostatectomy or radical radiotherapy at the ...
... National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) Trial design: A phase III study comparing radical prostatectomy or radical radiotherapy at the ...
in serum of prostate cancer patients and its clinical relevance
... a critical step in the natural course of prostate cancer and displays a fatal watershed in the individual medical history of most patients. Hypermethylation of the AR promoter downregulates AR expression and is thought to be one mechanism for development of HRPC, with a methylation frequency of 20% ...
... a critical step in the natural course of prostate cancer and displays a fatal watershed in the individual medical history of most patients. Hypermethylation of the AR promoter downregulates AR expression and is thought to be one mechanism for development of HRPC, with a methylation frequency of 20% ...
Open clinical uro-oncology trials in Canada
... Intergroup (NCIC CTG) Trial design: A phase III study comparing radical prostatectomy or radical radiotherapy at the time of initial diagnosis to active surveillance and selective intervention based on pre-specified biochemical, histological or clinical criteria. Patient population: Suitable candida ...
... Intergroup (NCIC CTG) Trial design: A phase III study comparing radical prostatectomy or radical radiotherapy at the time of initial diagnosis to active surveillance and selective intervention based on pre-specified biochemical, histological or clinical criteria. Patient population: Suitable candida ...
A Guide to Hormone Therapy for Prostate
... patients who are without evidence of cancer spread on radiologic tests but who demonstrate an abnormal level of an enzyme in the blood called PAP (Prostatic Acid Phosphatase). This finding was correlated with the probability that microscopic cancer spread had occurred. Currently, doctors are suspici ...
... patients who are without evidence of cancer spread on radiologic tests but who demonstrate an abnormal level of an enzyme in the blood called PAP (Prostatic Acid Phosphatase). This finding was correlated with the probability that microscopic cancer spread had occurred. Currently, doctors are suspici ...
hypofractionation for prostate cancer radiotherapy—what are the
... late-responding normal tissues, and much smaller than those for most tumors. 4. The problem with this estimate (1) of the ␣/ value for prostate, and almost all subsequent estimates (3–11, 13– 18) is that they involve comparing or equating EBRT results with BT results. There are many pertinent diffe ...
... late-responding normal tissues, and much smaller than those for most tumors. 4. The problem with this estimate (1) of the ␣/ value for prostate, and almost all subsequent estimates (3–11, 13– 18) is that they involve comparing or equating EBRT results with BT results. There are many pertinent diffe ...
CANCER RESEARCH: A SYSTEMS BIOLOGY APPROACH
... repair with increased age [3]. The nanotechnology associated with systems biology facilitates a more precise diagnosis, specific to the gene in which it is expressed. This increases the specificity of diagnosis so that more specific treatment options may be made available. Currently, chemotherapy an ...
... repair with increased age [3]. The nanotechnology associated with systems biology facilitates a more precise diagnosis, specific to the gene in which it is expressed. This increases the specificity of diagnosis so that more specific treatment options may be made available. Currently, chemotherapy an ...
jeannette m - Dr. Jeannette Potts
... JEANNETTE M. POTTS, M.D. Men’s Health GU Specialist CoFounder Vista Urology & Pelvic Pain Partners Biosketch : Specializing in office based urology, Prostatitis, urological pelvic pain syndromes in men and women, psychosexual well-being, PSA and cancer screening, ACTIVE active surveillance for Prost ...
... JEANNETTE M. POTTS, M.D. Men’s Health GU Specialist CoFounder Vista Urology & Pelvic Pain Partners Biosketch : Specializing in office based urology, Prostatitis, urological pelvic pain syndromes in men and women, psychosexual well-being, PSA and cancer screening, ACTIVE active surveillance for Prost ...
RADICAL PROSTATECTOMY AND QUALITY OF LIFE AMONG
... in most men. This finding is consistent with the current literature that reveals that urinary and sexual functions were the most common disease-specific side effects among men treated by radical prostatectomy for prostate cancer.20–24 Factors that can contribute to such high rates for urinary and se ...
... in most men. This finding is consistent with the current literature that reveals that urinary and sexual functions were the most common disease-specific side effects among men treated by radical prostatectomy for prostate cancer.20–24 Factors that can contribute to such high rates for urinary and se ...
Alcohol consumption and PSAdetected prostate cancer riskA
... Although the available evidence does not offer any clear indication for a clinically meaningful increase in prostate cancer risk, mainly due to substantial between-study heterogeneity, an effect of heavier alcohol drinking on high-grade disease in particular cannot be excluded. Between-study heterog ...
... Although the available evidence does not offer any clear indication for a clinically meaningful increase in prostate cancer risk, mainly due to substantial between-study heterogeneity, an effect of heavier alcohol drinking on high-grade disease in particular cannot be excluded. Between-study heterog ...
Should mass screening for prostate cancer be
... long latent phase is potentially advantageous for screening, but it appears that some tumours are very slow-growing and may never become clinically important (7). Men with these tumours often die from another cause (8). The mortality in men with very localized tumours is little different from that o ...
... long latent phase is potentially advantageous for screening, but it appears that some tumours are very slow-growing and may never become clinically important (7). Men with these tumours often die from another cause (8). The mortality in men with very localized tumours is little different from that o ...